The 17th Breast, Gynecological, and Immuno-oncology International Cancer Conference will be a must-attend event for those interested in the latest advancements in women’s health.
A key highlight will be the presentation by Professor Ahmed Ashour from the University of Oxford, who will discuss OvarianVax, a pioneering vaccine that could revolutionize ovarian cancer prevention.
“We’re reimagining how we approach this disease, OvarianVax holds the promise of empowering women with a proactive defense against a silent killer,” – Professor Ashour declared.
This bold vision, unveiled at the prestigious BGICC, is poised to ignite excitement and hope within the scientific community.
- Event Dates: January 23–24, 2025
- Venue: Hilton Heliopolis Hotel, Cairo, Egypt
- Register now.
Other posts featuring BGICC.
Ahmed A. Ahmed is a Professor of Gynaecological Oncology at the Nuffield Department of Obstetrics and Gynaecology at the University of Oxford and a Fellow of St Hugh’s College. Additionally, he is the founder of Singula Bio Ltd. He leads laboratory-based translational research in gynaecological oncology, focusing on the surgical, medical, and fundamental aspects of ovarian cancer. His work employs advanced technologies, including high-throughput microscopy, genomics, and proteomics, to identify and analyze key drivers and survival mechanisms of ovarian cancer micrometastases, aiming to develop targeted therapies.